Halasztelek, Hungary

Tamas Sohajda

This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignee: Cyclolab Cyclodextrin Research and Development Laboratory Ltd.. Active years: 2022-2023.

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Location History:

  • Halásztelek, HU (2022)
  • Halasztelek, HU (2023)

Company Filing History:


Years Active: 2022-2023

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Tamas Sohajda: Innovator in Cyclodextrin Research

Introduction

Tamas Sohajda is a notable inventor based in Halásztelek, Hungary. He has made significant contributions to the field of cyclodextrin research, holding 2 patents that focus on innovative processes and applications of cyclodextrins in medical treatments.

Latest Patents

His latest patents include a process for the purification of sulfobutylated cyclodextrins using specific ion exchange resins. This invention aims to reduce butane sultone hydrolysis products in reaction mixtures, utilizing a combination of strong anion exchange resin and cation exchange resin. Another significant patent involves the use of single isomer chemically modified cyclodextrins in the treatment or prevention of lysosomal neurodegenerative diseases. This invention specifically addresses isomer-pure, single isomer cyclodextrin salts that can be used in medications for lysosomal storage diseases.

Career Highlights

Tamas Sohajda is associated with Cyclolab Cyclodextrin Research and Development Laboratory Ltd., where he continues to advance research in cyclodextrin applications. His work has been instrumental in developing new methodologies that enhance the efficacy of cyclodextrins in various medical fields.

Collaborations

He has collaborated with notable colleagues such as Gabriella Hirschbergne Szejtli and István Puskás, contributing to a rich environment of innovation and research in cyclodextrin technology.

Conclusion

Tamas Sohajda's contributions to cyclodextrin research exemplify the impact of innovative thinking in the field of medicine. His patents reflect a commitment to improving therapeutic options for patients with lysosomal storage diseases.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…